Abbott gets CE mark for hepatitis B rapid diagnostic test
Healthcare firm Abbott has secured CE mark approval for Determine HBsAg 2, which is claimed to be the…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Feb 19
Healthcare firm Abbott has secured CE mark approval for Determine HBsAg 2, which is claimed to be the…
20 Feb 19
Medical technology company Axonics Modulation Technologies has announced positive top-line clinical aata from its ARTISAN-Sacral Neuromodulation (SNM) pivotal…
20 Feb 19
Life sciences company LabCorp has introduced a new assay in its therapeutic drug monitoring (TDM) DoseASSURE portfolio, to…
20 Feb 19
Institut de Radiofarmacia Aplicada de Barcelona (IRAB), a leading producer of imaging biomarkers for use in clinical research,…
20 Feb 19
Alcon, the global leader in eye care and a division of Novartis, will debut the iLux MGD treatment…
20 Feb 19
Irish medical technology firm Medtronic has secured breakthrough device designation from the US Food and Drug Administration (FDA)…
19 Feb 19
A new AI-powered smartphone app called Face2Gene can help doctors narrow down rare genetic disorders to ensure the…
19 Feb 19
Neural stimulation is a developing technology that has beneficial therapeutic effects in neurological disorders, such as Parkinson’s disease.…
19 Feb 19
Saniona, a research and development company focused on drugs for diseases of the central nervous system and eating…
19 Feb 19
French medical technology company Affluent Medical has announced positive results from its SCOPE 1 clinical trial validating the…